Dually-Listed Healthcare Stock Finds Mid-Week Success - InvestingChannel

Dually-Listed Healthcare Stock Finds Mid-Week Success

We don’t usually hyperfocus on the fundamental drivers in the penny stock realm simply because the majority of the action is headline-based or momentum trading, however today we have found ourselves chasing yet another earnings release that caused a penny stock to find tremendous success on Wednesday.

Traders were quick to grab up shares of WELL Health Technologies Corp. (TSX:WELL) (OTCQX:WHTCF) following an announcement that the company reported record quarterly revenue and net income for a first quarter. Revenues in Q1 2024 were $231.6 million, an increase of 37% YoY. Net income was $19.6 million (or $0.06 EPS).

Traders pushed shares trading on the Canadian side up to $3.98/share (+11.17%) at the session high.

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments. Virtual Services include EMR, billing and revenue cycle management solutions, digital apps, and cybersecurity.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

View the original article on AllPennyStocks.com

]]>

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire